Results 41 to 50 of about 36,145 (228)

Complement Anaphylatoxin C5a, Endothelial Dysfunction and Low-Grade Inflammation in Atherosclerotic Vascular Diseases

open access: yesCentral Asian Journal of Medical Sciences, 2018
Objectives: The objective of the paper is to summarize the evidence in atherosclerosis research regarding the relationship of complement C5a with low-grade inflammation, endothelial dysfunction, and atherosclerosis.
Gansuvd Shagdarsuren   +4 more
doaj   +1 more source

Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy

open access: yesBiomedicines, 2022
The complement system plays a key role in myasthenia gravis (MG). Anti-complement drugs are emerging as effective therapies to treat anti-acetylcholine receptor (AChR) antibody-positive MG patients, though their usage is still limited by the high costs ...
Nicola Iacomino   +11 more
doaj   +1 more source

Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura [PDF]

open access: yes, 2013
Complement dysregulation is key in the pathogenesis of atypical Haemolytic Uraemic Syndrome (aHUS), but no clear role for complement has been identified in Thrombotic Thrombocytopenic Purpura (TTP).
Heelas, E   +4 more
core   +1 more source

Reduced order modeling and analysis of the human complement system. [PDF]

open access: yesPLoS ONE, 2017
Complement is an important pathway in innate immunity, inflammation, and many disease processes. However, despite its importance, there are few validated mathematical models of complement activation.
Adithya Sagar   +4 more
doaj   +1 more source

Complement C5a receptors C5L2 and C5aR in renal fibrosis [PDF]

open access: yesAmerican Journal of Physiology-Renal Physiology, 2018
Complement factor C5a has two known receptors, C5aR, which mediates proinflammatory effects, and C5L2, a potential C5a decoy receptor. We previously identified C5a/C5aR signaling as a potent profibrotic pathway in the kidney. Here we tested for the first time the role of C5L2 in renal fibrosis.
Ina V. Martin   +8 more
openaire   +2 more sources

A peptide mimic of the chemotaxis inhibitory protein of Staphylococcus aureus: towards the development of novel anti-inflammatory compounds [PDF]

open access: yes, 2010
Complement factor C5a is one of the most powerful pro-inflammatory agents involved in recruitment of leukocytes, activation of phagocytes and other inflammatory responses.
AJ Wright   +26 more
core   +1 more source

Complement C5a receptors in the pituitary gland: expression and function [PDF]

open access: yesJournal of Endocrinology, 2008
Communication between the immune and endocrine system is important for the control of inflammation that is primarily mediated through the hypothalamic–pituitary–adrenal axis. The innate immune system rapidly responds to pathogens by releasing complement proteins that include the anaphylatoxins C3a and C5a.
Karen, Francis   +3 more
openaire   +2 more sources

Complement C5a-Induced Changes in Neutrophil Morphology During Inflammation. [PDF]

open access: yesScand J Immunol, 2017
AbstractThe complement and neutrophil defence systems, as major components of innate immunity, are activated during inflammation and infection. For neutrophil migration to the inflamed region, we hypothesized that the complement activation product C5a induces significant changes in cellular morphology before chemotaxis. Exposure of human neutrophils to
Denk S   +16 more
europepmc   +4 more sources

C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation [PDF]

open access: yes, 2015
Complement C1q is the activator of the classical pathway. However, it is now recognized that C1q can exert functions unrelated to complement activation.
Agostinis, C   +9 more
core   +3 more sources

Serum complement factor C5a in IgG4-related disease [PDF]

open access: yesAnnals of the Rheumatic Diseases, 2019
We read with great interest the correspondence by Umehara et al 1 which discussed the difficulties in the diagnosis of IgG4-related disease (IgG4-RD). They mention that increased IgG4 concentration is not a specific marker for IgG4-RD. Therefore, the markers for the diagnosis and the disease activity of IgG4-RD are demanded. Approximately a quarter of
Shoichi, Fukui   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy